Recon: Swissmedic begins rolling review of Moderna COVID vaccine; COVAX raises $2B

Posted 13 November 2020 | By Michael Mezher  Welcome to Regulatory Reconnaissance, your daily regulatory news and intelligence briefing. In Focus: US US government partners with pharmacy chains to increase COVID-19 vaccine access (Reuters) An FDA adviser on why his panel took a skeptical view on Biogen’s Alzheimer’s drug (STAT) Indivior hit with $600 million in [...]

Published November 13, 2020 at 02:17PM. Read full article at Stem Cells in the News Portal.